1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics in the United Kingdom, July 2020

Chronic Disease Analysis & Statistics in the United Kingdom, July 2020

1-30 of about 200 reports

Non-cystic Fibrosis Bronchiectasis (NCFB)- Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Non-cystic fibrosis bronchiectasis (NCFB) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Non-cystic fibrosis bronchiectasis epidemiology ...

  • Chronic Disease
  • Cystic Fibrosis
  • Pathology
  • Respiratory Disease
  • United Kingdom

Refractory Angina (RA)- Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Refractory Angina (RA) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Refractory Angina epidemiology in the 7MM, i.e., the United ...

  • Angina
  • Chronic Disease
  • Pathology
  • United Kingdom
  • United States

Type 2 Angiotensin II Receptor - Pipeline Review, H1 2020

  • $ 3500
  • April 2020
  • 55 pages

Type 2 Angiotensin II Receptor - Pipeline Review, H1 2020 Summary Type 2 Angiotensin II Receptor (Angiotensin II Type 2 Receptor or AGTR2) pipeline Target constitutes close to 10 molecules. Out of which ...

  • Chronic Disease
  • Pharmaceutical
  • Therapy
  • United Kingdom
  • Product Initiative

Familial Hypercholesterolemia - Epidemiology Forecast to 2030

  • $ 3750
  • April 2020
  • 100 pages

‘Familial Hypercholesterolemia (FH) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Familial Hypercholesterolemia (FH) epidemiology ...

  • Cardiovascular Disease
  • Chronic Disease
  • Pathology
  • United Kingdom
  • United States

Chronic Lower Back Pain (CLBP)- Epidemiology Forecast–2030

  • $ 3750
  • April 2020
  • 200 pages

‘Chronic Lower Back Pain (CLBP)- Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Chronic lower back pain (CLBP), historical and forecasted epidemiology as well as the ...

  • Chronic Disease
  • Chronic Pain
  • Pathology
  • Prescription Drug
  • United Kingdom

Diabetic Gastroparesis (DGp)- Epidemiology Forecast-2030

  • $ 3750
  • March 2020
  • 90 pages

‘Diabetic Gastroparesis (DGp)- Epidemiology Forecast-2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of DGp in the in 7MM covering the United States, ...

  • Chronic Disease
  • Diabetes
  • Pathology
  • France
  • United Kingdom

Succeeding in the 2020 Europe Respiratory Diseases Diagnostic Market for 8 Tests: France, Germany, Italy, Spain, UK

  • $ 5500
  • February 2020
  • 335 pages

Succeeding in the 2020 Europe Respiratory Diseases Diagnostic Market for 8 Tests: France, Germany, Italy, Spain, UK This new 335-page report provides analysis of the European respiratory disease testing ...

  • Chronic Disease
  • Pathology
  • Respiratory Disease
  • Europe
  • United Kingdom

Systemic Lupus Erythematosus and Lupus Nephritis: Epidemiology Forecast to 2028

  • $ 3995
  • January 2020
  • 57 pages

Systemic Lupus Erythematosus and Lupus Nephritis: Epidemiology Forecast to 2028 Summary Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of multifactorial origin that can affect any ...

  • Chronic Disease
  • Musculoskeletal Disorder
  • United Kingdom
  • United States
  • Forecast

ProAxsis Ltd - Product Pipeline Analysis, 2019 Update

  • $ 750
  • January 2020
  • 25 pages

Summary ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases.The company ...

  • Chronic Disease
  • Diagnostics
  • Immunodiagnostics
  • Respiratory Disease
  • United Kingdom

Type 1 Diabetes KOL Interview – UK

  • $ 599
  • January 2020
  • 13 pages

This interview with a UK Key Opinion Leader (KOL) provides insight into current therapies for type 1 diabetes, as well as pricing pressures within the diabetes market, the unmet needs in type 1 diabetes, ...

  • Chronic Disease
  • Diabetes
  • Type 1 Diabetes
  • United Kingdom
  • Market Size

Rheumatoid Arthritis Payer Interview – UK

  • $ 599
  • August 2019
  • 18 pages

Overview A UK payer provides insights into pricing and reimbursement dynamics and issues surrounding biosimilars, key marketed brands, and late-phase pipeline therapies for rheumatoid arthritis.

  • Arthritis
  • Chronic Disease
  • Medical Biotechnology
  • United Kingdom
  • Market Size

Allergic Rhinitis: Epidemiology Forecast to 2028

  • $ 3995
  • July 2019
  • 44 pages

Allergic Rhinitis: Epidemiology Forecast to 2028 Summary Allergic rhinitis (AR) is a chronic inflammatory condition of the nasal mucosa, caused by immunoglobulin E (IgE)-mediated early-phase and late-phase ...

  • Chronic Disease
  • Epidemiology
  • Respiratory Disease
  • United Kingdom
  • Forecast

Rheumatoid Arthritis KOL Interview – UK

  • $ 599
  • July 2019
  • 14 pages

A UK-based key opinion leader provides insights into prescribing habits, the most pressing unmet needs in the market, the role of biosimilars, key marketed brands, and late-phase pipeline therapies fo ...

  • Biosimilar
  • Chronic Disease
  • Medical Biotechnology
  • United Kingdom
  • Market Size

UK Respiratory Diseases Diagnostic Testing Market, 2019-2023: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

  • $ 1250
  • July 2019
  • 281 pages

UK Respiratory Diseases Diagnostic Testing Market, 2019-2023: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities ...

  • Chronic Disease
  • Medical Biotechnology
  • United Kingdom
  • Demand
  • Forecast

Prostaglandin D2 Receptor 2 - Pipeline Review, H1 2019

  • $ 3500
  • June 2019
  • 57 pages

Prostaglandin D2 Receptor 2 - Pipeline Review, H1 2019 Summary Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 ...

  • Asthma
  • Chronic Disease
  • Therapy
  • United Kingdom
  • Product Initiative

United Kingdom Diabetes Market Report: 2019 - 2024

  • $ 1999
  • June 2019
  • 91 pages

the analyst’s new report “United Kingdom Diabetes Market Report: 2019 - 2024” provides an analytical and statistical insight into the UK diabetes market. The report provides both current and future ...

  • Chronic Disease
  • Diabetes
  • Pathology
  • United Kingdom
  • Market Size

2019 UK Respiratory Diseases Diagnostic Testing Market: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

  • $ 1850
  • April 2019
  • 281 pages

2019 UK Respiratory Diseases Diagnostic Testing Market: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities fo ...

  • Chronic Disease
  • Infectious Disease
  • United Kingdom
  • Demand
  • Forecast

2019-2023 Competing in the UK Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 1950
  • March 2019
  • 281 pages

2019-2023 Competing in the UK Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and ...

  • Chronic Disease
  • Infectious Disease
  • United Kingdom
  • Demand
  • Forecast

Circassia Pharmaceuticals Plc (CIR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 33 pages

Summary Circassia Pharmaceuticals plc (Circassia) develops and manufactures drugs for the treatment of allergy and respiratory diseases such as asthma.The company’s marketed products include Niox used ...

  • Chronic Disease
  • Pharmaceutical
  • United Kingdom
  • Demand
  • Circassia Pharmaceuticals plc

Synairgen Plc (SNG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 31 pages

Summary Synairgen plc (Synairgen) is a drug discovery and development company, which focuses on the development of novel drugs for the treatment of respiratory diseases such as asthma and chronic obstructive ...

  • Chronic Disease
  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Synairgen plc

Immupharma Plc (IMM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 36 pages

Summary ImmuPharma Plc (ImmuPharma) develops novel drugs for the treatment of serious medical conditions with unmet medical need.ImmuPharma develops drugs for the treatment of lupus, cancer, moderate to ...

  • Chronic Disease
  • Musculoskeletal Disorder
  • Pharmaceutical
  • United Kingdom
  • ImmuPharma plc

Vectura Group Plc (VEC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 71 pages

Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform.It develops inhalation products, to help patients ...

  • Chronic Disease
  • Pharmaceutical
  • United Kingdom
  • Company Financials
  • Vectura Group plc

Abcodia Ltd - Product Pipeline Analysis, 2018 Update

  • $ 750
  • October 2018
  • 36 pages

Summary Abcodia Ltd (Abcodia) is a clinical stage company that offers commercial development of novel, scientifically validated tests for the early detection of cancer.The company offers Roca Test, a blood ...

  • Chronic Disease
  • Ovarian Cancer
  • United Kingdom
  • Company
  • Abcodia Ltd.

Omega Diagnostics Group Plc (ODX) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 43 pages

Summary Omega Diagnostics Group Plc (Omega) is a biotechnology company that provides in-vitro diagnostic products.The company provides products in the areas of allergy, food intolerance, autoimmune disease ...

  • Chronic Disease
  • United Kingdom
  • World
  • Company
  • Company Financials

Randox Laboratories Ltd - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 26 pages

Summary Randox Laboratories Ltd (Randox) is a clinical diagnostic company that manufactures and provides clinical diagnostic solutions to laboratories.The company’s products include biochip analyzers, ...

  • Chronic Disease
  • Laboratory
  • United Kingdom
  • Deals & Alliance
  • Randox Laboratories Ltd.

Datamonitor Healthcare Type 2 Diabetes KOL Interview – UK

  • $ 599
  • October 2018
  • 11 pages

Overview In this discussion with a UK KOL, we cover topics related to the shift in market dynamics in recent years and what goes into the decision-making process when prescribing antidiabetics for patients. ...

  • Antidiabetics
  • Chronic Disease
  • Type 2 Diabetes
  • United Kingdom
  • Forecast

SomaLogic Inc - Product Pipeline Analysis, 2018 Update

  • $ 750
  • August 2018
  • 48 pages

Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products.The company’s products include SOMAscan ...

  • Chronic Disease
  • Diagnostics
  • Pathology
  • United Kingdom
  • SomaLogic, Inc.

Acute Ischemic Stroke: Epidemiology Forecast to 2027

  • $ 3995
  • July 2018
  • 50 pages

Acute Ischemic Stroke: Epidemiology Forecast to 2027 Summary Acute Ischemic Stroke (AIS) occurs due to an obstructed blood vessel that supplies blood to the brain, and is the predominant type of stroke, ...

  • Chronic Disease
  • Stroke
  • United Kingdom
  • United States
  • Forecast

Horizon Discovery Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • July 2018
  • 280 pages

Horizon Discovery Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Horizon Discovery Group Plc Mergers & Acquisitions (M&A), Partnerships ...

  • Chronic Disease
  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Horizon Discovery

LifeArc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • July 2018
  • 92 pages

LifeArc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s LifeArc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...

  • Cancer
  • Chronic Disease
  • Pharmaceutical
  • United Kingdom
  • Corporate Finance

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on